Ranitidine in duodenal ulcer - Incidence of healing and effect of smoking

Digestive Diseases and Sciences

Volumn 27, Issue 8, 1982, Pages 712-715

  Korman, Melvyn G ^a   Hansky, Jack ^a   Merrett, Andrew C ^a   Schmidt, Graham T ^a  

^a MONASH MEDICAL CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTACID AGENT; HISTAMINE H2 RECEPTOR; PLACEBO; RANITIDINE;

DUODENUM ULCER; MAJOR CLINICAL STUDY; RECURRENT PEPTIC ULCER; SMALL INTESTINE; SMOKING; STOMACH; THERAPY;

ADULT; AGED; ANTI-ULCER AGENTS; CLINICAL TRIALS; DOUBLE-BLIND METHOD; DUODENAL ULCER; FEMALE; FURANS; HUMAN; MALE; MIDDLE AGE; RANITIDINE; SMOKING;

EID: 0019997628     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/BF01393766     Document Type: Article

References (11)

1. Long-term treatment with cimetidine in duodenal ulceration
2. Histamine H2 receptor antagonists in the treatment of duodenal ulcer
3. Cimetidine in the treatment of duodenal ulcer
4. Effect of ranitidine a new H2 antagonist on gastric and pancreatic secretion in duodenal ulcer patients
5. Cimetidine and ranitidine in duodenal ulcer
6. Treatment of duodenal ulcer with ranitidine, a new histamine H2 receptor antagonist
7. Influence of smoking on healing rate of duodenal ulcer in response to cimetidine or high dose antacid
8. Healing of duodenal ulcer with an antacid regime
9. Women and duodenal ulcer
10. Relapse rate of duodenal ulcer after cessation of long-term cimetidine treatment: A double-blind trial study